313 related articles for article (PubMed ID: 16399567)
21. Diagnosis and manifestations of chronic graft-versus-host disease.
Filipovich AH
Best Pract Res Clin Haematol; 2008 Jun; 21(2):251-7. PubMed ID: 18503990
[TBL] [Abstract][Full Text] [Related]
22. Design and Patient Characteristics of the Chronic Graft-versus-Host Disease Response Measures Validation Study.
Chronic GVHD Consortium
Biol Blood Marrow Transplant; 2018 Aug; 24(8):1727-1732. PubMed ID: 29476954
[TBL] [Abstract][Full Text] [Related]
23. Histopathologic diagnosis of chronic graft-versus-host disease of the oral mucosa according to the National Institutes of Health Consensus.
Santos PS; Coracin FL; Barros JC; Gallottini MH
Einstein (Sao Paulo); 2014 Apr; 12(2):204-10. PubMed ID: 25003927
[TBL] [Abstract][Full Text] [Related]
24. Graft-versus-tumor effect according to type of graft-versus-host disease defined by National Institutes of Health consensus criteria and associated outcomes.
Cho BS; Lee SE; Song HH; Lee JH; Yahng SA; Eom KS; Kim YJ; Kim HJ; Lee S; Min CK; Cho SG; Kim DW; Lee JW; Min WS; Park CW
Biol Blood Marrow Transplant; 2012 Jul; 18(7):1136-43. PubMed ID: 22261380
[TBL] [Abstract][Full Text] [Related]
25. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IIb. The 2020 Preemptive Therapy Working Group Report.
Pidala J; Kitko C; Lee SJ; Carpenter P; Cuvelier GDE; Holtan S; Flowers ME; Cutler C; Jagasia M; Gooley T; Palmer J; Randolph T; Levine JE; Ayuk F; Dignan F; Schoemans H; Tkaczyk E; Farhadfar N; Lawitschka A; Schultz KR; Martin PJ; Sarantopoulos S; Inamoto Y; Socie G; Wolff D; Blazar B; Greinix H; Paczesny S; Pavletic S; Hill G
Transplant Cell Ther; 2021 Aug; 27(8):632-641. PubMed ID: 33836313
[TBL] [Abstract][Full Text] [Related]
26. 2014 National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: preface to the series.
Pavletic SZ; Vogelsang GB; Lee SJ
Biol Blood Marrow Transplant; 2015 Mar; 21(3):387-8. PubMed ID: 25572033
[No Abstract] [Full Text] [Related]
27. Ancillary therapy and supportive care of chronic graft-versus-host disease: national institutes of health consensus development project on criteria for clinical trials in chronic Graft-versus-host disease: V. Ancillary Therapy and Supportive Care Working Group Report.
Couriel D; Carpenter PA; Cutler C; Bolaños-Meade J; Treister NS; Gea-Banacloche J; Shaughnessy P; Hymes S; Kim S; Wayne AS; Chien JW; Neumann J; Mitchell S; Syrjala K; Moravec CK; Abramovitz L; Liebermann J; Berger A; Gerber L; Schubert M; Filipovich AH; Weisdorf D; Schubert MM; Shulman H; Schultz K; Mittelman B; Pavletic S; Vogelsang GB; Martin PJ; Lee SJ; Flowers ME
Biol Blood Marrow Transplant; 2006 Apr; 12(4):375-96. PubMed ID: 16545722
[TBL] [Abstract][Full Text] [Related]
28. Toward a Better Understanding of the Atypical Features of Chronic Graft-Versus-Host Disease: A Report from the 2020 National Institutes of Health Consensus Project Task Force.
Cuvelier GDE; Schoettler M; Buxbaum NP; Pinal-Fernandez I; Schmalzing M; Distler JHW; Penack O; Santomasso BD; Zeiser R; Angstwurm K; MacDonald KPA; Kimberly WT; Taylor N; Bilic E; Banas B; Buettner-Herold M; Sinha N; Greinix HT; Pidala J; Schultz KR; Williams KM; Inamoto Y; Cutler C; Griffith LM; Lee SJ; Sarantopoulos S; Pavletic SZ; Wolff D
Transplant Cell Ther; 2022 Aug; 28(8):426-445. PubMed ID: 35662591
[TBL] [Abstract][Full Text] [Related]
29. Histopathology of Graft-vs-Host Disease of Gastrointestinal Tract and Liver: An Update.
Salomao M; Dorritie K; Mapara MY; Sepulveda A
Am J Clin Pathol; 2016 May; 145(5):591-603. PubMed ID: 27247365
[TBL] [Abstract][Full Text] [Related]
30. Pathology of graft-versus-host disease in the gastrointestinal tract.
Washington K; Jagasia M
Hum Pathol; 2009 Jul; 40(7):909-17. PubMed ID: 19524102
[TBL] [Abstract][Full Text] [Related]
31. Uptake and use of recommendations for the diagnosis, severity scoring and management of chronic GVHD: an international survey of the EBMT-NCI Chronic GVHD Task Force.
Duarte RF; Greinix H; Rabin B; Mitchell SA; Basak G; Wolff D; Madrigal JA; Pavletic SZ; Lee SJ
Bone Marrow Transplant; 2014 Jan; 49(1):49-54. PubMed ID: 23955633
[TBL] [Abstract][Full Text] [Related]
32. Histologic analysis has a prognostical value in colorectal biopsies assessed for suspicion of graft-versus-host disease.
Sauvestre F; Belleannée G; Bréal C; Mohr C; Fong HI; Cossin S; Tabrizi R; Milpied N; Vigouroux S; Goussot JF; Marty M
Virchows Arch; 2018 Feb; 472(2):213-220. PubMed ID: 29167990
[TBL] [Abstract][Full Text] [Related]
33. Neurological manifestations of chronic graft-versus-host disease after allogeneic haematopoietic stem cell transplantation: report from the Consensus Conference on Clinical Practice in chronic graft-versus-host disease.
Grauer O; Wolff D; Bertz H; Greinix H; Kühl JS; Lawitschka A; Lee SJ; Pavletic SZ; Holler E; Kleiter I
Brain; 2010 Oct; 133(10):2852-65. PubMed ID: 20846944
[TBL] [Abstract][Full Text] [Related]
34. Clinical update on graft-versus-host disease in children.
Goddard DS; Horn BN; McCalmont TH; Cordoro KM
Semin Cutan Med Surg; 2010 Jun; 29(2):92-105. PubMed ID: 20579598
[TBL] [Abstract][Full Text] [Related]
35. Chronic graft-versus-host disease.
Lee SJ; Vogelsang G; Flowers ME
Biol Blood Marrow Transplant; 2003 Apr; 9(4):215-33. PubMed ID: 12720215
[TBL] [Abstract][Full Text] [Related]
36. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IIa. The 2020 Clinical Implementation and Early Diagnosis Working Group Report.
Kitko CL; Pidala J; Schoemans HM; Lawitschka A; Flowers ME; Cowen EW; Tkaczyk E; Farhadfar N; Jain S; Steven P; Luo ZK; Ogawa Y; Stern M; Yanik GA; Cuvelier GDE; Cheng GS; Holtan SG; Schultz KR; Martin PJ; Lee SJ; Pavletic SZ; Wolff D; Paczesny S; Blazar BR; Sarantopoulos S; Socie G; Greinix H; Cutler C
Transplant Cell Ther; 2021 Jul; 27(7):545-557. PubMed ID: 33839317
[TBL] [Abstract][Full Text] [Related]
37. Incidence and outcome of chronic graft-versus-host disease using National Institutes of Health consensus criteria.
Jagasia M; Giglia J; Chinratanalab W; Dixon S; Chen H; Frangoul H; Engelhardt B; Goodman S; Greer J; Kassim A; Morgan D; Ruffner K; Schuening F
Biol Blood Marrow Transplant; 2007 Oct; 13(10):1207-15. PubMed ID: 17889358
[TBL] [Abstract][Full Text] [Related]
38. Chronic graft-versus-host disease in the era of reduced-intensity conditioning.
Subramaniam DS; Fowler DH; Pavletic SZ
Leukemia; 2007 May; 21(5):853-9. PubMed ID: 17377592
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of NIH consensus criteria for classification of late acute and chronic GVHD.
Vigorito AC; Campregher PV; Storer BE; Carpenter PA; Moravec CK; Kiem HP; Fero ML; Warren EH; Lee SJ; Appelbaum FR; Martin PJ; Flowers ME;
Blood; 2009 Jul; 114(3):702-8. PubMed ID: 19470693
[TBL] [Abstract][Full Text] [Related]
40. Predictive models for ocular chronic graft-versus-host disease diagnosis and disease activity in transplant clinical practice.
Curtis LM; Datiles MB; Steinberg SM; Mitchell SA; Bishop RJ; Cowen EW; Mays J; McCarty JM; Kuzmina Z; Pirsl F; Fowler DH; Gress RE; Pavletic SZ
Haematologica; 2015 Sep; 100(9):1228-36. PubMed ID: 26088932
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
